First Patient In Boston’s ZERO AF Blazer® Open-Irrigated Temperature Ablation Catheter Trial



First Patient Treated In The Boston Scientific ZERO AF Clinical Trial To Evaluate The Safety And Performance Of The Blazer® Open-Irrigated Temperature Ablation Catheter (via PR Newswire)

NATICK, Mass., Jan. 16, 2013 /PRNewswire/ — The first patient has been treated in the Boston Scientific Corporation (NYSE: BSX) ZERO AF clinical trial to evaluate the safety and effectiveness of the Blazer® Open-Irrigated Temperature Ablation Catheter in patients with symptomatic, drug refractory…